Cargando…

Effects of infrared laser moxibustion on cancer‐related fatigue: A randomized, double‐blind, placebo‐controlled trial

BACKGROUND: Fatigue is the most common symptom negatively affecting the quality of life of patients with cancer. The objective of the current study was to evaluate the preliminary efficacy and safety of 10.6‐μm infrared laser moxibustion for cancer‐related fatigue (CRF). METHODS: The authors conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Huijuan, Mao, Jun J., Guo, Menghu, Cheng, Ke, Wei, Jianzi, Shen, Xubo, Shen, Xueyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132039/
https://www.ncbi.nlm.nih.gov/pubmed/27495269
http://dx.doi.org/10.1002/cncr.30189
_version_ 1782470990737965056
author Mao, Huijuan
Mao, Jun J.
Guo, Menghu
Cheng, Ke
Wei, Jianzi
Shen, Xubo
Shen, Xueyong
author_facet Mao, Huijuan
Mao, Jun J.
Guo, Menghu
Cheng, Ke
Wei, Jianzi
Shen, Xubo
Shen, Xueyong
author_sort Mao, Huijuan
collection PubMed
description BACKGROUND: Fatigue is the most common symptom negatively affecting the quality of life of patients with cancer. The objective of the current study was to evaluate the preliminary efficacy and safety of 10.6‐μm infrared laser moxibustion for cancer‐related fatigue (CRF). METHODS: The authors conducted a randomized, placebo‐controlled trial among 78 patients with cancer who were diagnosed with CRF. The group treated with infrared laser moxibustion received 10.6 μm of infrared laser moxibustion on the ST36 (bilateral), CV4, and CV6 acupoints. Each participant received a 20‐minute treatment session 3 times per week for 4 weeks. The sham group received the same treatment duration on the same acupoints, but without infrared laser output. The outcome was change in fatigue as measured by the Chinese version of the Brief Fatigue Inventory between groups at week 4 with additional evaluation at week 8 for durability of treatment effects. A mixed effects model was used to evaluate the difference in treatment effect over time. RESULTS: Among those randomized, 61 patients (78%) completed the entire study. At the end of the intervention, the individuals in the group treated with the laser were found to have significantly less fatigue than those in the sham group (3.01 vs 4.40; P = .002). The improvement in fatigue persisted to week 8, favoring the group treated with laser moxibustion (3.03 vs 4.26; P = .006). Laser moxibustion was safe, with 3 cases of mild local erythema that resolved without medical intervention reported. CONCLUSIONS: Infrared laser moxibustion appeared to be safe and efficacious for improving CRF in a Chinese patient population. Larger studies in more racial/ethnically diverse populations are needed to confirm the benefit of this technique for fatigue in patients with cancer. Cancer 2016;122:3667‐72. © 2016 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
format Online
Article
Text
id pubmed-5132039
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-51320392016-12-02 Effects of infrared laser moxibustion on cancer‐related fatigue: A randomized, double‐blind, placebo‐controlled trial Mao, Huijuan Mao, Jun J. Guo, Menghu Cheng, Ke Wei, Jianzi Shen, Xubo Shen, Xueyong Cancer Original Articles BACKGROUND: Fatigue is the most common symptom negatively affecting the quality of life of patients with cancer. The objective of the current study was to evaluate the preliminary efficacy and safety of 10.6‐μm infrared laser moxibustion for cancer‐related fatigue (CRF). METHODS: The authors conducted a randomized, placebo‐controlled trial among 78 patients with cancer who were diagnosed with CRF. The group treated with infrared laser moxibustion received 10.6 μm of infrared laser moxibustion on the ST36 (bilateral), CV4, and CV6 acupoints. Each participant received a 20‐minute treatment session 3 times per week for 4 weeks. The sham group received the same treatment duration on the same acupoints, but without infrared laser output. The outcome was change in fatigue as measured by the Chinese version of the Brief Fatigue Inventory between groups at week 4 with additional evaluation at week 8 for durability of treatment effects. A mixed effects model was used to evaluate the difference in treatment effect over time. RESULTS: Among those randomized, 61 patients (78%) completed the entire study. At the end of the intervention, the individuals in the group treated with the laser were found to have significantly less fatigue than those in the sham group (3.01 vs 4.40; P = .002). The improvement in fatigue persisted to week 8, favoring the group treated with laser moxibustion (3.03 vs 4.26; P = .006). Laser moxibustion was safe, with 3 cases of mild local erythema that resolved without medical intervention reported. CONCLUSIONS: Infrared laser moxibustion appeared to be safe and efficacious for improving CRF in a Chinese patient population. Larger studies in more racial/ethnically diverse populations are needed to confirm the benefit of this technique for fatigue in patients with cancer. Cancer 2016;122:3667‐72. © 2016 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. John Wiley and Sons Inc. 2016-08-06 2016-12-01 /pmc/articles/PMC5132039/ /pubmed/27495269 http://dx.doi.org/10.1002/cncr.30189 Text en © 2016 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Mao, Huijuan
Mao, Jun J.
Guo, Menghu
Cheng, Ke
Wei, Jianzi
Shen, Xubo
Shen, Xueyong
Effects of infrared laser moxibustion on cancer‐related fatigue: A randomized, double‐blind, placebo‐controlled trial
title Effects of infrared laser moxibustion on cancer‐related fatigue: A randomized, double‐blind, placebo‐controlled trial
title_full Effects of infrared laser moxibustion on cancer‐related fatigue: A randomized, double‐blind, placebo‐controlled trial
title_fullStr Effects of infrared laser moxibustion on cancer‐related fatigue: A randomized, double‐blind, placebo‐controlled trial
title_full_unstemmed Effects of infrared laser moxibustion on cancer‐related fatigue: A randomized, double‐blind, placebo‐controlled trial
title_short Effects of infrared laser moxibustion on cancer‐related fatigue: A randomized, double‐blind, placebo‐controlled trial
title_sort effects of infrared laser moxibustion on cancer‐related fatigue: a randomized, double‐blind, placebo‐controlled trial
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132039/
https://www.ncbi.nlm.nih.gov/pubmed/27495269
http://dx.doi.org/10.1002/cncr.30189
work_keys_str_mv AT maohuijuan effectsofinfraredlasermoxibustiononcancerrelatedfatiguearandomizeddoubleblindplacebocontrolledtrial
AT maojunj effectsofinfraredlasermoxibustiononcancerrelatedfatiguearandomizeddoubleblindplacebocontrolledtrial
AT guomenghu effectsofinfraredlasermoxibustiononcancerrelatedfatiguearandomizeddoubleblindplacebocontrolledtrial
AT chengke effectsofinfraredlasermoxibustiononcancerrelatedfatiguearandomizeddoubleblindplacebocontrolledtrial
AT weijianzi effectsofinfraredlasermoxibustiononcancerrelatedfatiguearandomizeddoubleblindplacebocontrolledtrial
AT shenxubo effectsofinfraredlasermoxibustiononcancerrelatedfatiguearandomizeddoubleblindplacebocontrolledtrial
AT shenxueyong effectsofinfraredlasermoxibustiononcancerrelatedfatiguearandomizeddoubleblindplacebocontrolledtrial